Nukkleus (NASDAQ:NUKK) Stock Price Up 8.7% – Still a Buy?

Nukkleus Inc. (NASDAQ:NUKK) shares rose 8.7% during trading on Monday . The stock traded as high as $2.11 and last traded at $2.0650. Approximately 1,016,541 shares were traded during mid-day trading, a decline of 54% from the average daily volume of 2,219,789 shares. The stock had previously closed at $1.90.

Analysts Set New Price Targets

A number of equities analysts have recently commented on NUKK shares. Wall Street Zen upgraded Nukkleus from a “sell” rating to a “hold” rating in a research note on Sunday, November 23rd. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a report on Wednesday, December 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

Nukkleus Stock Up 8.7%

The business has a 50-day moving average price of $3.21 and a 200-day moving average price of $5.11. The firm has a market capitalization of $34.38 million, a P/E ratio of 0.13 and a beta of -6.76.

Insiders Place Their Bets

In other news, major shareholder Sc Capital Ii Sponsor Llc bought 255,000 shares of the company’s stock in a transaction that occurred on Friday, November 28th. The stock was acquired at an average price of $10.00 per share, for a total transaction of $2,550,000.00. Following the transaction, the insider directly owned 255,000 shares of the company’s stock, valued at $2,550,000. This trade represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Anastasiia Kotaieva sold 75,000 shares of the firm’s stock in a transaction that occurred on Monday, December 29th. The stock was sold at an average price of $4.09, for a total transaction of $306,750.00. Following the sale, the insider directly owned 75,000 shares of the company’s stock, valued at approximately $306,750. The trade was a 50.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 394,952 shares of company stock valued at $1,745,457. Company insiders own 7.90% of the company’s stock.

Institutional Investors Weigh In On Nukkleus

Hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets bought a new stake in shares of Nukkleus during the second quarter valued at approximately $56,000. UBS Group AG raised its position in shares of Nukkleus by 23.3% during the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after acquiring an additional 15,223 shares during the last quarter. Ausdal Financial Partners Inc. bought a new position in Nukkleus in the third quarter valued at about $105,000. Geode Capital Management LLC boosted its holdings in Nukkleus by 193.7% in the fourth quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after acquiring an additional 82,252 shares during the last quarter. Finally, LPL Financial LLC acquired a new stake in Nukkleus in the fourth quarter worth about $120,000. Institutional investors own 12.47% of the company’s stock.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.